BiomX Inc. (PHGE)

BiomX Statistics

Total Valuation

BiomX has a market cap or net worth of $10.85 million. The enterprise value is $7.93 million.

Market Cap	10.85M
Enterprise Value	7.93M

Important Dates

The next estimated earnings date is Tuesday, March 24, 2026, before market open.

Earnings Date	Mar 24, 2026
Ex-Dividend Date	n/a

Share Statistics

BiomX has 1.59 million shares outstanding. The number of shares has increased by 115.25% in one year.

Current Share Class	1.59M
Shares Outstanding	1.59M
Shares Change (YoY)	+115.25%
Shares Change (QoQ)	+21.02%
Owned by Insiders (%)	4.81%
Owned by Institutions (%)	17.05%
Float	1.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.87

Current Ratio	0.87
Quick Ratio	0.70
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,546.00

Financial Efficiency

Return on equity (ROE) is -316.90% and return on invested capital (ROIC) is -114.13%.

Return on Equity (ROE)	-316.90%
Return on Assets (ROA)	-78.85%
Return on Invested Capital (ROIC)	-114.13%
Return on Capital Employed (ROCE)	5,187.92%
Weighted Average Cost of Capital (WACC)	12.15%
Revenue Per Employee	n/a
Profits Per Employee	-$1.81M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BiomX has paid $7,000 in taxes.

Income Tax	7,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.68% in the last 52 weeks. The beta is 1.70, so BiomX's price volatility has been higher than the market average.

Beta (5Y)	1.70
52-Week Price Change	-44.68%
50-Day Moving Average	4.17
200-Day Moving Average	7.36
Relative Strength Index (RSI)	62.66
Average Volume (20 Days)	93,735

Short Selling Information

The latest short interest is 133,660, so 8.39% of the outstanding shares have been sold short.

Short Interest	133,660
Short Previous Month	51,433
Short % of Shares Out	8.39%
Short % of Float	10.74%
Short Ratio (days to cover)	0.05

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-30.92M
Pretax Income	-36.19M
Net Income	-36.20M
EBITDA	-28.00M
EBIT	-30.92M
Earnings Per Share (EPS)	-$22.19

Balance Sheet

The company has $4.36 million in cash and $1.44 million in debt, with a net cash position of $2.92 million or $1.83 per share.

Cash & Cash Equivalents	4.36M
Total Debt	1.44M
Net Cash	2.92M
Net Cash Per Share	$1.83
Equity (Book Value)	-1.30M
Book Value Per Share	-12.50
Working Capital	-804,000

Cash Flow

In the last 12 months, operating cash flow was -$26.39 million and capital expenditures -$2,000, giving a free cash flow of -$26.39 million.

Operating Cash Flow	-26.39M
Capital Expenditures	-2,000
Free Cash Flow	-26.39M
FCF Per Share	-$16.56

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BiomX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-115.25%
Shareholder Yield	-115.25%
Earnings Yield	-333.54%
FCF Yield	-243.17%

Analyst Forecast

The average price target for BiomX is $26.00, which is 281.79% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$26.00
Price Target Difference	281.79%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-13.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 25, 2025. It was a reverse split with a ratio of 1:19.

Last Split Date	Nov 25, 2025
Split Type	Reverse
Split Ratio	1:19

Scores

Altman Z-Score	n/a
Piotroski F-Score	1